Northern Trust’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.07M | Buy |
145,171
+111,611
| +333% | +$5.44M | ﹤0.01% | 2264 |
|
2025
Q1 | $723K | Sell |
33,560
-397
| -1% | -$8.55K | ﹤0.01% | 3415 |
|
2024
Q4 | $913K | Buy |
33,957
+2,170
| +7% | +$58.3K | ﹤0.01% | 3434 |
|
2024
Q3 | $342K | Buy |
+31,787
| New | +$342K | ﹤0.01% | 3695 |
|
2024
Q2 | – | Sell |
-8,018
| Closed | -$148K | – | 4425 |
|
2024
Q1 | $148K | Sell |
8,018
-11
| -0.1% | -$202 | ﹤0.01% | 3978 |
|
2023
Q4 | $127K | Buy |
8,029
+1,631
| +25% | +$25.9K | ﹤0.01% | 4049 |
|
2023
Q3 | $121K | Hold |
6,398
| – | – | ﹤0.01% | 3962 |
|
2023
Q2 | $145K | Buy |
6,398
+801
| +14% | +$18.1K | ﹤0.01% | 3938 |
|
2023
Q1 | $142K | Buy |
5,597
+322
| +6% | +$8.18K | ﹤0.01% | 3977 |
|
2022
Q4 | $79.8K | Hold |
5,275
| – | – | ﹤0.01% | 4167 |
|
2022
Q3 | $66K | Buy |
5,275
+355
| +7% | +$4.44K | ﹤0.01% | 4244 |
|
2022
Q2 | $48K | Hold |
4,920
| – | – | ﹤0.01% | 4420 |
|
2022
Q1 | $82K | Sell |
4,920
-605
| -11% | -$10.1K | ﹤0.01% | 4407 |
|
2021
Q4 | $140K | Buy |
5,525
+2,039
| +58% | +$51.7K | ﹤0.01% | 4317 |
|
2021
Q3 | $156K | Sell |
3,486
-135
| -4% | -$6.04K | ﹤0.01% | 4266 |
|
2021
Q2 | $146K | Sell |
3,621
-15,099
| -81% | -$609K | ﹤0.01% | 4258 |
|
2021
Q1 | $996K | Sell |
18,720
-781
| -4% | -$41.6K | ﹤0.01% | 3587 |
|
2020
Q4 | $780K | Buy |
19,501
+254
| +1% | +$10.2K | ﹤0.01% | 3602 |
|
2020
Q3 | $1.1M | Buy |
19,247
+13,346
| +226% | +$761K | ﹤0.01% | 3359 |
|
2020
Q2 | $436K | Buy |
5,901
+3,480
| +144% | +$257K | ﹤0.01% | 3590 |
|
2020
Q1 | $120K | Buy |
2,421
+959
| +66% | +$47.5K | ﹤0.01% | 3783 |
|
2019
Q4 | $112K | Buy |
1,462
+207
| +16% | +$15.9K | ﹤0.01% | 3914 |
|
2019
Q3 | $50K | Sell |
1,255
-47
| -4% | -$1.87K | ﹤0.01% | 4048 |
|
2019
Q2 | $44K | Sell |
1,302
-179
| -12% | -$6.05K | ﹤0.01% | 4098 |
|
2019
Q1 | $79K | Sell |
1,481
-688
| -32% | -$36.7K | ﹤0.01% | 3969 |
|
2018
Q4 | $102K | Buy |
2,169
+13
| +0.6% | +$611 | ﹤0.01% | 3918 |
|
2018
Q3 | $190K | Buy |
2,156
+287
| +15% | +$25.3K | ﹤0.01% | 3880 |
|
2018
Q2 | $195K | Buy |
1,869
+90
| +5% | +$9.39K | ﹤0.01% | 3866 |
|
2018
Q1 | $142K | Buy |
1,779
+901
| +103% | +$71.9K | ﹤0.01% | 3890 |
|
2017
Q4 | $119K | Sell |
878
-29
| -3% | -$3.93K | ﹤0.01% | 3937 |
|
2017
Q3 | $147K | Sell |
907
-1
| -0.1% | -$162 | ﹤0.01% | 3865 |
|
2017
Q2 | $137K | Sell |
908
-4,719
| -84% | -$712K | ﹤0.01% | 3902 |
|
2017
Q1 | $878K | Buy |
5,627
+331
| +6% | +$51.6K | ﹤0.01% | 3389 |
|
2016
Q4 | $1.1M | Buy |
5,296
+508
| +11% | +$106K | ﹤0.01% | 3323 |
|
2016
Q3 | $1.1M | Sell |
4,788
-9
| -0.2% | -$2.06K | ﹤0.01% | 3319 |
|
2016
Q2 | $989K | Buy |
4,797
+2,286
| +91% | +$471K | ﹤0.01% | 3350 |
|
2016
Q1 | $638K | Buy |
2,511
+4
| +0.2% | +$1.02K | ﹤0.01% | 3396 |
|
2015
Q4 | $860K | Buy |
2,507
+156
| +7% | +$53.5K | ﹤0.01% | 3369 |
|
2015
Q3 | $599K | Buy |
+2,351
| New | +$599K | ﹤0.01% | 3452 |
|